Search
for

    Sort by

    Research 151–180 of 770

    1. Oral retinoids-present status British Journal of Dermatology · 1980 · 108 citations
    2. Alternative Medicine for Hair Loss InTech eBooks · 2017 · 1 citations
    3. National scientific medical meeting 1996 abstracts Irish Journal of Medical Science (1971 -) · 1996
    4. Viewpoint 3 Experimental dermatology · 2008
    5. Analysis of the Working Principle of Hair Dye Applied and Computational Engineering · 2026
    6. Case Report:Pregnancy and birth in a mild phenotype of Alström syndrome Frontiers in Genetics · 2022 · 5 citations
    7. Research on the Mechanism of Hair Dyeing Agents and Strategies for Health Risks Reduction Applied and Computational Engineering · 2025
    8. Twenty-Five and Up (25Up) Study: A New Wave of the Brisbane Longitudinal Twin Study Twin research and human genetics · 2019 · 18 citations
    9. Overview of alopecia areata for managed care and payer stakeholders in the United States Journal of managed care & specialty pharmacy · 2023
    10. The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19 Frontiers in Pharmacology · 2022 · 15 citations
    11. Scalp acupoint catgut embedding combined with topical 5% minoxidil tincture to improve male androgenetic alopecia: protocol for a randomised controlled trial BMJ Open · 2025
    12. Refractory Postsurgical Hypothyroidism in Nephrotic Syndrome Journal of the Endocrine Society · 2021
    13. Androgen sensitivity gateway to COVID‐19 disease severity Drug Development Research · 2020 · 123 citations
    14. Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels Frontiers in Pharmacology · 2021 · 13 citations
    15. COVID-19 pandemic: what about the gonads? Hormones · 2021 · 9 citations
    16. Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology Arabian Journal of Chemistry · 2023 · 7 citations
    17. The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review Viruses · 2024 · 6 citations
    18. ACE1 rs1799752 polymorphism is not associated with long-COVID symptomatology in previously hospitalized COVID-19 survivors Journal of Infection · 2022 · 6 citations
    19. Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata Dermatologica Sinica · 2025 · 4 citations
    20. The association of medications and supplements with human male reproductive health: a systematic review Fertility and Sterility · 2023 · 4 citations
    21. Neurosarcoidosis Occurring 6 Years after Onset of Vogt-Koyanagi-Harada Disease Case Reports in Ophthalmology · 2019 · 3 citations
    22. Novel potential therapeutic targets of alopecia areata Frontiers in Immunology · 2023 · 1 citations
    23. Alterations in the Hair Follicle Bacteriome and Mycobiome in Androgenetic Alopecia: A Cross-Sectional Study of 72 Patients and 24 Healthy Controls Clinical Cosmetic and Investigational Dermatology · 2026
    24. Alopecia in a Linear Pattern Clinical Cases in Dermatology · 2022
    25. Cheating on forensic hair testing? Detection of potential biomarkers for cosmetically altered hair samples using untargeted hair metabolomics Analyst · 2020 · 12 citations
    26. Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies Frontiers in Medicine · 2020 · 10 citations
    27. Roles of steroid receptors in the lung and COVID-19 Essays in Biochemistry · 2021 · 9 citations
    28. Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2 Clinical Therapeutics · 2021 · 22 citations
    29. COVID-19: Pulmonary and Extra Pulmonary Manifestations Frontiers in Public Health · 2021 · 132 citations
    30. Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1) Journal of the American Academy of Dermatology · 2024 · 63 citations